These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21332692)

  • 1. Cyclosporin combined with methotrexate in two patients with recalcitrant subacute cutaneous lupus erythematosus.
    Klein A; Vogt T; Wenzel SM; Fleck M; Landthaler M
    Australas J Dermatol; 2011 Feb; 52(1):43-7. PubMed ID: 21332692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate treatment for refractory subacute cutaneous lupus erythematosus.
    Kuhn A; Specker C; Ruzicka T; Lehmann P
    J Am Acad Dermatol; 2002 Apr; 46(4):600-3. PubMed ID: 11907517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thalidomide therapy of cutaneous lupus erythematosus].
    Bohmeyer J; Achenbach A; Westenberger M; Stadler R
    Hautarzt; 2002 Nov; 53(11):744-8. PubMed ID: 12402138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid improvement of subacute cutaneous lupus erythematosus with low-dose methotrexate.
    Böhm L; Uerlich M; Bauer R
    Dermatology; 1997; 194(3):307-8. PubMed ID: 9187859
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients.
    Wenzel J; Brähler S; Bauer R; Bieber T; Tüting T
    Br J Dermatol; 2005 Jul; 153(1):157-62. PubMed ID: 16029342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous lupus erythematosus: a personal approach to management.
    Callen JP
    Australas J Dermatol; 2006 Feb; 47(1):13-27. PubMed ID: 16405478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulse cyclophosphamide treatment for severe refractory cutaneous lupus erythematosus.
    Raptopoulou A; Linardakis C; Sidiropoulos P; Kritikos HD; Boumpas DT
    Lupus; 2010 May; 19(6):744-7. PubMed ID: 20179172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovative management of lupus erythematosus.
    Knott HM; Martínez JD
    Dermatol Clin; 2010 Jul; 28(3):489-99. PubMed ID: 20510759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolate sodium for subacute cutaneous lupus erythematosus resistant to standard therapy.
    Kreuter A; Tomi NS; Weiner SM; Huger M; Altmeyer P; Gambichler T
    Br J Dermatol; 2007 Jun; 156(6):1321-7. PubMed ID: 17408395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalidomide for the treatment of resistant cutaneous lupus: efficacy and safety of different therapeutic regimens.
    Cuadrado MJ; Karim Y; Sanna G; Smith E; Khamashta MA; Hughes GR
    Am J Med; 2005 Mar; 118(3):246-50. PubMed ID: 15745722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subacute cutaneous lupus erythematosus: report of a patient who subsequently developed a meningioma and whose skin lesions were treated with isotretinoin.
    Richardson TT; Cohen PR
    Cutis; 2000 Sep; 66(3):183-8. PubMed ID: 11006852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with oral cyclosporin A of a case of vesicular cutaneous lupus erythematosus in a rough collie.
    Font A; Bardagi M; Mascort J; Fondevila D
    Vet Dermatol; 2006 Dec; 17(6):440-2. PubMed ID: 17083576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of herpes zoster during pimecrolimus use for the treatment of subacute cutaneous lupus erythematosus.
    Tatlican S; Eren C; Atacan D; Dalgic U; Canpolat F; Eskioglu F
    J Dermatolog Treat; 2010 Sep; 21(5):322-3. PubMed ID: 19832287
    [No Abstract]   [Full Text] [Related]  

  • 14. Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative.
    Lampropoulos CE; Sangle S; Harrison P; Hughes GR; D'Cruz DP
    Rheumatology (Oxford); 2004 Nov; 43(11):1383-5. PubMed ID: 15266063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of topical tacrolimus 0.3% in clobetasol propionate 0.05% ointment in therapy-resistant cutaneous lupus erythematosus: a cohort study.
    Madan V; August PJ; Chalmers RJ
    Clin Exp Dermatol; 2010 Jan; 35(1):27-30. PubMed ID: 19549244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment.
    Jewell ML; McCauliffe DP
    J Am Acad Dermatol; 2000 Jun; 42(6):983-7. PubMed ID: 10827400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Systemic therapy of cutaneous lupus erythematosus].
    Ochsendorf F
    J Dtsch Dermatol Ges; 2004 Mar; 2(3):229-30; author reply 230. PubMed ID: 16281642
    [No Abstract]   [Full Text] [Related]  

  • 18. [Subacute cutaneous lupus. Evolutive and therapeutic features of a series of 24 cases].
    Versapuech J; Beylot-Barry M; Doutre MS; Beylot C
    Presse Med; 2000 Oct; 29(29):1596-9. PubMed ID: 11072357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case reports of etanercept in inflammatory dermatoses.
    Norman R; Greenberg RG; Jackson JM
    J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S139-42. PubMed ID: 16488329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leflunomide in subacute cutaneous lupus erythematosus - two sides of a coin.
    Suess A; Sticherling M
    Int J Dermatol; 2008 Jan; 47(1):83-6. PubMed ID: 18173611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.